Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
What is the medication in QWO
As with any peptide not yet FDA-approved, long-term safety data remains limited
Storage & Handling Before reconstitution: the lyophilized vial is stable refrigerated
The BPC157 + TB500 + GHK-Cu Glow Blend can be used in laboratory and preclinical designs such as: These use cases reflect research environments where defined peptide blends contribute to structured exploratory workflows
FOXO4-DRI acts as a competitive inhibitor of this interaction binding directly to the transactivation domain 2 (TAD2) of p53, displacing FOXO4, and allowing phosphorylated p53 to be exported from the nucleus and directed to mitochondria, where it activates BAX, triggers caspase-3 cleavage (via the p53/BCL-2/Caspase-3 signalling pathway), and drives cell-intrinsic apoptosis
US$ 26.28
US$ 25.39
US$ 29.82
US$ 24.58
US$ 23.44
US$ 26.96